<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03867825</url>
  </required_header>
  <id_info>
    <org_study_id>2014/2312</org_study_id>
    <nct_id>NCT03867825</nct_id>
  </id_info>
  <brief_title>Hemodynamic Monitoring of Newborn Infants With Impedance Cardiography Versus Echocardiography; a Validation Study</brief_title>
  <official_title>Hemodynamic Monitoring of Newborn Infants With Impedance Cardiography Versus Echocardiography; a Validation Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital of North Norway</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Knut Helge Kaspersen, MD</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Per Ivar Kaaresen, MD, PhD</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Nils Thomas Songstad, MD, PhD</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Ganesh Acharya, Professor</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University Hospital of North Norway</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Background:

      Impedance cardiography (ICG) is a noninvasive method for continuous left cardiac output
      monitoring based on measurement of thoracic electrical bioimpedance. The objective of this
      study is to validate an ICG device by investigating the agreement in cardiac output (CO; left
      ventricular output x heart rate) measurements performed by ICG and echocardiography. The ICG
      device (PhysioFlow) has a new filter technology reducing signal noise and enabling
      measurements in patients who are moving freely.

      Material and Methods

        -  Design: Prospective observational study.

        -  Inclusion: 30 healthy term infants between 24 and 48 hours of age, after parental
           consent

        -  Methods: Continuous measurement with ICG over a 30 min period and point of care
           echocardiography

        -  Primary outcome: Agreement (bis and precision) between measurement of CO with ICG and
           echocardiography.

        -  Secondary outcomes: Agreement between other echocardiographic indices of myocardial
           function and ICG parameters (early diastolic filling ratio, cardiac index, ventricular
           ejection time and left cardiac work index).

        -  Statistics: Agreement between ICG and echocardiography data will be evaluated using
           Bland-Altman statistics, including the calculation of mean bias (average difference
           between measurements) with corresponding standard deviation and lower and upper limits
           of agreements (95% confidence interval).
    </textblock>
  </brief_summary>
  <overall_status>Withdrawn</overall_status>
  <why_stopped>
    Never got medical equipment that worked properly
  </why_stopped>
  <start_date type="Anticipated">January 2020</start_date>
  <completion_date type="Anticipated">December 2020</completion_date>
  <primary_completion_date type="Anticipated">December 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Cardiac output</measure>
    <time_frame>one hour</time_frame>
    <description>Stroke volume x heart rate</description>
  </primary_outcome>
  <enrollment type="Actual">0</enrollment>
  <condition>Hemodynamics</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Non-invasive hemodynamic monitoring</intervention_name>
    <description>Impedance cardiography</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Term healthy infants
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Newborn infants

        Exclusion Criteria:

          -  Infants &gt; 1 month of age
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>1 Month</maximum_age>
  </eligibility>
  <verification_date>March 2019</verification_date>
  <study_first_submitted>March 6, 2019</study_first_submitted>
  <study_first_submitted_qc>March 6, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">March 8, 2019</study_first_posted>
  <last_update_submitted>March 6, 2019</last_update_submitted>
  <last_update_submitted_qc>March 6, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">March 8, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University Hospital of North Norway</investigator_affiliation>
    <investigator_full_name>Claus Klingenberg</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

